Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 2202-2208

  Lechman, Eric R ^a   Jaffurs, Daniel ^a   Ghivizzani, Steven C ^b   Gambotto, Andrea ^a   Kovesdi, Imre ^c   Mi, Zhibao ^a   Evans, Christopher H ^a   Robbins, Paul D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Megabios Corporation   (United States)

^c GENVEC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE MATRIX; CONTROLLED STUDY; FEMALE; GENE TRANSFER; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTOSIS; MARKER GENE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RHEUMATOID ARTHRITIS; SYNOVITIS; VIRUS RECOMBINANT;

ADENOVIRUSES, HUMAN; ANIMALS; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 4, HUMAN; INJECTIONS, INTRA-ARTICULAR; INTERLEUKIN-10; KNEE JOINT; LUMINESCENT PROTEINS; RABBITS; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 0033566812     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Moreland, L. W., L. W. Heck, Jr., and W. J. Koopman 1997. Biologic agents for treating rheumatoid arthritis: concepts and progress. Arthritis Rheum. 40:397.
2. Moreland, L. W., G. R. Margolies, L. W. Heck, P. A. Saway, C. Blosch, R. Hanna, and W. J. Koopman. 1996. Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis. J. Rheumatol. 23:1849.
3. Arend, W. P., M. Malyak, M. F. Smith, Jr., T. D. Whisenand, J. L. Slack, J. E. Sims, J. G. Giri, and S. K. Dower. 1994. Binding of IL-1α, IL-1β and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J. Immunol. 153:4766.
4. Arend, W.P. 1993. Inlerleukin-1 receptor antagonist. Adv. Immunol. 54:167.
5. Elliot, M. J., R. N. Maini, M. Feldmann, J. R. Kalden, C. Antoni, J. S. Smolen, B. Leeb, F. C. Breeveld, J. D. Macfarlane, and H. Bijl. 1994. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105.
6. Arend, W. P., and J. M. Dayer 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor in rheumatoid arthritis. Arthritis Rheum. 38:151.
7. Feldmann, M., M. J. Elliot, J. N. Woody, and R. N. Maini. 1997. Anti-TNF-α therapy of rheumatoid arthritis. Adv. Immunol. 64:283.
8. Evans, C. H., S. C. Ghivizzani, R. Kang, T. Muzzonigro, M. C. Wasko, J. H. Herndon, and P. D. Robbins. 1999. Gene therapy for rheumatic diseases. Arthritis Rheum. 43:1.
9. Florentine, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
10. Moore, K. W., A. O'Garra, R. de Waal Malafyt, P. Vieri, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
11. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figden, and J. E. DeVries. 1991. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
12. Bogdon, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin-10. J. Exp. Med. 174:1549.
13. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1994. IL-10 inhibits transcription of cytokine genes in human peripheral blood. J. Immunol. 153:811.
14. de Waal Malefyt, R. D., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. deVries. 1991. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
15. Ding, L., P. S. Linsley, L. Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224.
16. Willems, F., A. Marchant, J. P. Delville, C. Gerard, A. Delvaux, T. Velu, M. de Boer, and M. Goldman. 1994. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol. 24:1007.
17. Buelens, C., F. Williams, A. Delvaux, G. Peirand, J. P. Delville, T. Velu, and M. Goldman 1995. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol. 25:2668.
18. Go, N. F., B. E. Castle, R. Barrett, R. Kastelein, W. Dang, T. R. Mosmann, K. W. Moore, and M. Howard. 1990. Interleukin-10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1625.
19. + lymphocyte migration. J. Immunol. 151:4545.
20. Taga, K., B. Cherney, and G. Tosato. 1993. IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int. Immunol. 12:1599.
21. Levy, Y., and J. C. Brouet. 1994. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J. Clin. Invest. 93:424.
22. Katsikis, P. D., C. Q. Chu, F. M. Brennan, R. N. Miani, and M. Feldmann. 1994. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J. Exp. Med. 179:1517.
23. Cush, J. J., J. B. Splawski, R. Thomas, J. E. McFarlin, H. Schulze-Koops, L. S. Davis, K. Fujita, and P. E. Lipsky. 1995. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 38:96.
24. Moore, K. W., P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 248:1230.
25. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deminger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:1207.
26. DeVries, J. E. 1995. Immunosuppressive and anti-inflammatory properties of interleukin-10. Ann. Med. 27:537.
27. Drazen, K. E., L. Wu, D. Bullington, and A. Shaken. 1996. Viral IL-10 gene therapy inhibits TNF-α and IL-1β, not IL-6, in the newborn endotoxemic mouse. J. Pediatr. Surg. 31:411.
28. Qin, L., K. D. Chevin, Y. Ding, H. Tahara, J. P. Favarro, J. E. Woodward, T. Suzuki, P. D. Robbins, M. Y. Lotze, and J. S. Bromberg. 1996. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J. Immunol. 156:2316.
29. Suzuki, T., H. Tahara, S. Narula, K. W. Moore, P. D. Robbins, and M. T. Lotze, Viral interleukin-10 (vIL-10), the human herpes virus-4 cellular IL-10 (cIL-10) homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med. 102:477.
30. Yeh, P., and M. Penicaudet. 1997. Advances in adenoviral vectors: from genetic engineering to their biology. FASEB J. 11:615.
31. Graham, F. L., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456.
32. Mittereder, N., K. L. March, and B. C. Trapnell. 1996. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70: 7498.
33. Glynn, L. E. 1968. The chronicity of inflammation and its significance in rheumatoid arthritis. Ann. Rheum. Dis. 27:105.
34. Taskiran, D., M. Stefanovic-Racic, H. I. Georgescu, and C. H. Evans. 1994. Nitric-oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem. Biophys. Res. Commun. 200:142.
35. Farndale, R. W., D. J. Buttle, and A. J. Barnette. 1986. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta 883:173.
36. Ghivizzani, S. C., E. R. Lechman, R. Kang, C. Tio, J. Kolls, C. H. Evans, and P. D. Robbins. 1998. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc. Natl. Acad. Sci. USA 95:4613.
37. Müller-Ladner, U., C. H. Evans, B. N. Franklin, C. R. Robets, R. E. Gay, P. D. Robbins, and S. Gay. 1999. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum. In press.
38. Ma, Y., S. Thornton, L. E. Duwel, G. P. Biovin, E. H. Giannini, J. M. Leiden, J. A. Bluestone, and R. Hirsch. 1998. Inhibition of collagen-induced arthritis in mice by viral 1L-10 gene transfer. J. Immunol 161:1516.
39. Apparailly, F., C. Verwaerde, C. Jacquet, C. Auriault, J. Sany, and C. Jorgenson. 1998. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J. Immunol. 160:5213.
40. Whalen, J. D., E. R. Lechman, C. A. Carlos, K. Weiss, I. Kovesdi, P. D. Robbins, and C. H. Evans. 1999. Adenoviral transfer of the viral IL-10 gene peri-articularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J. Immunol. 162:3625.
41. Qin, L., Y. Ding, D. R. Pahud, N. D. Robson, A. Shaked, and J. S. Bromeberg. 1997. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum. Gene Ther. 8:1365.